What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 2pm

APEX Biologix

We are the complete resource for regenerative medicine offering training courses nationwide, full ma

An industry leader, we are dedicated to the science and research of regenerative medicine and its potential by supplying physicians with the best products on the market to treat their patients

07/29/2026

A recent peer-reviewed study evaluating PRP preparations produced with the XCELL 60 mL single-spin system reported an average of 10.8 billion total available platelets (TAPs) in the final PRP product.

But what does that number represent?

TAPs is calculated using the platelet concentration and final product volume, providing a measure of the total platelet dose available within the preparation after PRP processing.

In the study, 70 consecutive clinical samples from two independent sites produced an average TAP value of 10.8 billion platelets in a final volume of approximately 6 mL. The system also achieved an average platelet capture rate of 83% and an approximately eightfold increase in platelet concentration compared with baseline whole blood.

Platelet dose is only one characteristic of a PRP formulation. Researchers also evaluated platelet capture rate, red blood cell reduction, leukocyte composition, and final product volume to more completely characterize the resulting preparations.

The findings demonstrated consistent platelet recovery and the ability to produce PRP formulations with different leukocyte profiles using a single-spin processing approach.

Explore the peer-reviewed research and technology behind the XCELL PRP System. Check the link in bio!

07/28/2026

The APEX Biologix team joined clinicians at Orthosono, the Las Vegas Regenerative Medicine and MSK Ultrasound Course, for three days of education focused on the science and clinical application of regenerative medicine.

Throughout the conference, our team participated in meaningful clinical conversations, demonstrated the XCELL PRP System, and shared information about the broader XCELL product portfolio, including XCELL PC and XCELL BMC.

Thank you to the Orthosono faculty, organizers, and clinicians who contributed to an engaging educational experience and to Ansley Morris for representing APEX Biologix and connecting with the clinical community.

07/22/2026

Quality, consistency, and ease of use matter in every clinical workflow.

Shounuck Patel, DO, shares his experience with APEX Biologix, highlighting the ease of use of the system, the ability to evaluate platelet capture, and the importance of producing a quality PRP product.

We’re proud to support clinicians with systems designed to help make biologic processing more streamlined while providing meaningful insight into the final product.

Thank you, Dr. Patel, for sharing your experience with APEX Biologix.

07/20/2026

APEX Biologix is proud to be attending Orthosono, the Las Vegas Regenerative Medicine and MSK Ultrasound Course, the longest-running private MSK ultrasound and regenerative medicine training course, established in 2008.

The course brings clinicians together for practical, evidence-based education covering regenerative medicine, orthobiologics, MSK ultrasound, ultrasound-guided injection techniques, and more.

If you're attending, connect with the APEX team and meet Ansley Morris.

📅 July 23–25, 2026

We look forward to seeing you there!

07/15/2026

Insights from Dr. Jason Piraino and Dr. Ariana DeMers on the evolving discussion around PRP, protein concentrate (PC), and the role of biologics in musculoskeletal care.

This session explores current research perspectives on inflammation, tissue response, and biologic variability, along with how these concepts are being considered in relation to tissue type, healing phases, and clinical decision-making frameworks.

Topics include how PRP and PC are being evaluated within the broader context of musculoskeletal care and how clinicians are thinking about biologic selection based on patient and pathology-specific factors.

For access to additional educational content, visit the APEX Biologix Resource Library.

07/13/2026

APEX Biologix is proud to be attending the 2026 American Society of Pain & Neuroscience (ASPN) Annual Conference, where leading physicians, researchers, and industry experts come together to discuss the latest advancements in pain management and regenerative medicine.

If you're attending, stop by Booth #229 to connect with the APEX team and meet Loren Deren, Vice President of Clinical Development.

We'd love to discuss orthobiologics, physician education, and how we're supporting the advancement of regenerative medicine through innovative solutions and hands-on training.

📍 Booth #229
📅 July 17–19, 2026
📍 Fontainebleau Miami Beach | Miami Beach, FL

We look forward to seeing you there!

07/10/2026

🔬 Meet the APEX Research & Laboratory Team

At APEX Biologix, our Research & Laboratory Team brings together expertise in translational research, biomedical engineering, clinical development, and laboratory science. Through scientific research, product development, quality initiatives, and physician collaboration, this team helps advance the science behind regenerative medicine.
We're proud to introduce the talented individuals whose expertise supports our mission.

🧬 Dr. Ryan Dregalla – Vice President of Translational Research
With a Ph.D. in Cell & Molecular Biology, Dr. Dregalla has dedicated his career to advancing orthobiologic research, tissue-based technologies, laboratory quality systems, and translational science. His work has contributed to peer-reviewed publications, intellectual property, and research programs supporting the advancement of regenerative medicine.

🧬 Loren Deren, https://hubs.ly/Q04p8p8R0., CTBS – Vice President of Clinical Development
With more than 15 years of experience in regenerative medicine, biotechnology, and medical devices, Loren combines scientific knowledge with physician education and clinical development to help translate research into meaningful clinical applications.

🧬 Dr. Taylor Lansberry – Research Scientist
A biomedical engineer with a Ph.D. in Biomedical Engineering, Taylor specializes in translational biomaterials, drug delivery, and preclinical research. Her experience spans complex experimental design, data analysis, and product development, helping bring innovative scientific concepts closer to clinical application.

🧬 Jessica McCluskey – Research & Laboratory Operations
Jessica brings extensive experience in orthobiologic research, laboratory operations, and medical device development. She has contributed to in vitro research, laboratory assay development, research study ex*****on, and quality-focused initiatives, while supporting multiple peer-reviewed scientific publications and collaborative research projects that advance regenerative medicine.

Together, the APEX Research & Laboratory Team is committed to advancing regenerative medicine through research, innovation, and scientific excellence.

07/08/2026

Peer-reviewed evidence matters.

As regenerative medicine continues to evolve, transparent reporting and standardized biologic characterization have become increasingly important.

We're excited to share that research evaluating the XCELL PRP System has now been published in Bioengineering.

Independent clinicians evaluated 70 consecutive clinical samples across two outpatient sites using the XCELL 60 mL single-spin system.

The study demonstrated:

• 83% platelet capture rate
• Average 8x platelet concentration over baseline, with individual samples reaching up to 10x
• Ability to produce PRP formulations with varying leukocyte profiles without sacrificing platelet yield
• Single-spin architecture offering reduced processing time, simplified workflow, minimized cellular mechanical trauma, and reduced contamination risk through fewer transfer steps

The publication also reinforces an important discussion occurring across regenerative medicine:

🩸 𝗡𝗼𝘁 𝗮𝗹𝗹 𝗣𝗥𝗣 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲.

Understanding platelet dose, cellular composition, and processing methodology may help clinicians better characterize the biologic therapies they deliver.

We are proud to contribute peer-reviewed data to the growing body of regenerative medicine literature.

Review the peer-reviewed evidence and explore the complete study at the link in bio.

07/06/2026

APEX Biologix is proud to be attending the 2026 American Orthopaedic Society for Sports Medicine Annual Meeting, where physicians, researchers, and industry leaders will come together to explore the latest advancements shaping orthopaedic sports medicine.

If you're attending, stop by Booth #406 to connect with the team. We'd love to discuss the evolving role of orthobiologics, physician education, and what's next in sports medicine innovation.

📍 Booth #406
📅 July 8 - 10, 2026
🌲Seattle Convention Center | Seattle, WA

Not attending this year? Visit https://hubs.ly/Q04ngCX70 to explore regenerative medicine education, clinical resources, live webinars, and hands-on training opportunities designed to support physicians at every stage of their orthobiologic journey.

07/04/2026

This Independence Day, we celebrate the spirit of innovation, dedication, and progress that continues to drive healthcare forward.

As we gather with family, friends, and our communities, we also take a moment to honor and thank those who have served and continue to serve our country.

Wishing you a safe, meaningful, and happy Fourth of July. 🇺🇸

Address

19321 US Highway 19 N
Clearwater, FL
33764

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 2pm

Website

http://www.ApexBiologix.com/

Alerts

Be the first to know and let us send you an email when APEX Biologix posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Clearwater?